Sumaphi, Jenie Grace S.

HRN: 03-52-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
CEFUROXIME 500MG (TAB)
07/20/2026
07/27/2026
PO
500mg
BID X 7 Days
S/P NSVD; UTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: